A 5-gene signature based on TLR4 signaling as predictive of risk of distant relapse in breast cancer treated with taxane-anthracycline neoadjuvant chemotherapy.
Joseph A. Pinto
No relevant relationships to disclose
Claudio J Flores
No relevant relationships to disclose
Priscila I. Valdiviezo
No relevant relationships to disclose
Alfredo Aguilar
No relevant relationships to disclose
Juan F. Suazo
No relevant relationships to disclose
Mayer Zaharia
No relevant relationships to disclose
Richard Dyer
No relevant relationships to disclose
Carlos Vigil
No relevant relationships to disclose
Carlos S. Vallejos
No relevant relationships to disclose
Henry Gomez
No relevant relationships to disclose